✦ LIBER ✦

9138 Prognostic model to predict outcomes in non-small cell lung cancer patients treated with erlotinib as a salvage treatment

✍ Scribed by Kim, S.; Lee, J.; Park, Y.; Park, J.; Ahn, J.; Im, Y.; Kang, W.; Park, K.; Ahn, M.

Book ID: 122514924
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 47 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71851-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic model to predict outcomes in

Prognostic model to predict outcomes in nonsmall cell lung cancer patients treated with gefitinib as a salvage treatment

✍ Min Jae Park; Jeeyun Lee; Jung Yong Hong; Moon Ki Choi; Joon Ho Yi; Su Jin Lee; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB 👁 2 views

## Abstract ## BACKGROUND: A prognostic model based on clinical parameters for nonsmall cell lung cancer (NSCLC) patients treated with gefitinib (250 mg/day) as a salvage therapy was devised. ## METHODS: Clinical data regarding a total of 316 metastatic or recurrent NSCLC patients who were treat

Predictive and prognostic value of early

Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinib

✍ Tiseo, Marcello; Ippolito, Massimo; Scarlattei, Maura; Spadaro, Pietro; Cosentin 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 587 KB

A Phase II Trial of Erlotinib As Front-L

A Phase II Trial of Erlotinib As Front-Line Treatment in Clinically Selected Patients With Non–Small-Cell Lung Cancer

✍ Athanasios G. Pallis; Alexandra Voutsina; Nikolaos Kentepozidis; Stylianos Giass 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 374 KB

Salvage treatment with erlotinib after g

Salvage treatment with erlotinib after gefitinib failure in advanced non-small-cell lung cancer patients with poor performance status: A matched-pair case–control study

✍ Daxian Luo; Meijuan Huang; Xinxing Zhang; Min Yu; Bingwen Zou; Yanying Li; Jianl 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 289 KB

PCN9 OBSERVATIONAL STUDY OF PATIENTS WIT

PCN9 OBSERVATIONAL STUDY OF PATIENTS WITH NON SMALL CELL LUNG CANCER (NSCLC) TREATED BY ERLOTINIB: CLINICAL PRACTICES AND MAIN OUTCOMES IN FRANCE

✍ A Vergnenegre; I Monnet; C Chouaid; J Hureaux; J Mazières; G Quéré; JN Lombard; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

ERCC1 expression as a prognostic and pre

ERCC1 expression as a prognostic and predictive factor in patients with non-small cell lung cancer: a meta-analysis

✍ Jingwei Jiang; Xiaohua Liang; Xinli Zhou; Ruofan Huang; Zhaohui Chu; Qiong Zhan 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 548 KB